At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.
Position Summary
The Director, Global Medical Neuroscience, Psychiatry, Mood Disorders will serve as a medical and scientific leader responsible for supporting the development and execution of the global disease and asset specific medical strategy for BMS's Mood Disorders portfolio. This role will drive specific strategic initiatives and medical programs across the asset lifecycle, while building strong cross-functional relationships with key stakeholders, including US and Global Commercial, Global Drug Development, Research, HEOR, Regulatory Affairs, and global medical stakeholders. The Director will partner closely with the US Medical Strategy to execute Mood Disorders medical activities, contribute to the Mood Disorders medical vision, and represent BMS externally with the medical and scientific community.
This position reports to the Executive Director, Mood Disorders, Medical Product Lead, Global Medical Neuroscience, Psychiatry.
Key Responsibilities
Medical Strategy Execution
Lead and/or participate in Medical Matrix Team activities and meetings, contributing to the development, planning, and execution of the Medical Plan aligned with disease area and product strategies.
Represent Medical in strategic and cross-functional forums, contributing to the direction of Mood Disorders program across the development and commercialization lifecycle.
Monitor and translate the evolving Mood Disorders treatment landscape — including competitive intelligence, emerging science, and regulatory trends — into actionable medical strategies.
Contribute strategic input into asset development decisions and lifecycle management activities for Mood Disorders assets.
Support the development and execution of a comprehensive, Integrated Medical Plan that is aligned with disease area and portfolio priorities.
Partner closely with US Medical Strategy, Mood Disorders, to ensure consistent execution of the Medical Plan while supporting clear ownership, decision rights, and escalation pathways between strategy and execution.
Cross-Functional Collaboration
Act as a strategic partner to Commercial, Market Access, Regulatory, R&D, and HEOR functions, ensuring medical perspectives are integrated into Brand Planning, launch readiness, and other commercialization activities.
Represent Medical Strategy on cross-functional brand teams, contributing to program-level decisions and planning processes.
Collaborate with Commercialization & Access organizations to align medical and commercial plans for the Mood Disorders franchise.
Coordinate with Marketing and matrix partners to communicate clinical trial results, treatment guidelines, and other clinical data internally and externally.
External Engagement & Scientific Leadership
Build and maintain relationships with thought leaders, key opinion leaders, academic centers, clinical researchers, and patient advocacy organizations within the Mood Disorders space.
Represent BMS externally, presenting scientific data and strategy at medical congresses, advisory boards, and scientific forums.
Support the strategy for Thought Leader identification, mapping, profiling, and engagement for the Mood Disorders franchise.
Support BMS-sponsored clinical and non-registrational research activities, including real-world evidence generation strategies.
People Leadership & Organizational Development
Support with mentoring and development of medical team members, fostering a high-performance,…